Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells and impede their attack - blocking the ...

According to a new comprehensive report from The Insight Partners, the Global Organoid Market is witnessing significant ...

Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular Targets Symposium in Barcelona LONDON - Oct. 24, 2024 ...

Scientists have created a 3D-printed model to mimic the specific conditions that spur the spread of cancer cells. The model, published in the journal Life Science Alliance, allows researchers to study ...

In the realm of oncology, the concept of 'metabolic rewiring' has expanded beyond aerobic glycolysis to encompass various metabolic strategies that cancer cells employ for survival and progression, ...

Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies for the treatment of ...

Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells and impede ...

Scientists have created a 3D-printed model to mimic the specific conditions that spur the spread of cancer cells. The model, ...

“We and others have previously observed that alterations in STK11 and KEAP1 can promote an immunosuppressive tumor microenvironment and together might be responsible for half or more of the primary ...

A significant obstacle in treating ovarian cancer is the tumor microenvironment—the complex ecosystem of cells, molecules and ...